Selective Targeting of T and B Cell Populations by Alemtuzumab in the Treatment of Multiple Sclerosis - touchNEUROLOGY
Alemtuzumab
1 Campath ® (alemtuzumab) Millennium & ILEX Partners, LP Oncologic Drugs Advisory Committee December 14, ppt download
Multiple sclerosis | Neurology Clinical Practice
Mechanism of action of alemtuzumab. Alemtuzumab lyses lymphocytes via... | Download Scientific Diagram
Intractable and highly active relapsing multiple sclerosis – rol | NDT
Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML
References in Getting specific: monoclonal antibodies in multiple sclerosis - The Lancet Neurology
Biomedicines | Free Full-Text | Vasculitis: From Target Molecules to Novel Therapeutic Approaches | HTML
Identification and development of new therapeutics for multiple sclerosis: Trends in Pharmacological Sciences
Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation. - Abstract - Europe PMC
Ibrutinib combinations in CLL therapy: scientific rationale and clinical results | Blood Cancer Journal
Mitigating alemtuzumab-associated autoimmunity in MS | Neurology Neuroimmunology & Neuroinflammation
Cells | Free Full-Text | The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis | HTML
Alemtuzumab for multiple sclerosis: the new concept of immunomodulation | Multiple Sclerosis and Demyelinating Disorders | Full Text
JPM | Free Full-Text | Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis | HTML
Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects | HTML
Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis
Frontiers | New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions | Immunology
SciELO - Brasil - New immunosuppressive agents in pediatric transplantation New immunosuppressive agents in pediatric transplantation
Intractable and highly active relapsing multiple sclerosis – rol | NDT
